Adaptive Hemostatic Compositions for Niche Environments
Legal Citation
Summary of the Inventive Concept
The present invention relates to specialized hemostatic compositions and methods for inducing hemostasis in unique operational environments, such as high-altitude, high-temperature, underwater, remote, and high-security settings.
Background and Problem Solved
The original patent disclosed a hemostatic composition comprising an anion exchanger and a calcium salt. However, these compositions may not be effective in specific environments with extreme conditions, such as low oxygen levels, high temperatures, high water pressure, or security screening radiation. The present inventive concept addresses these limitations by adapting the hemostatic composition to function effectively in these niche environments.
Detailed Description of the Inventive Concept
The new inventive concept involves modifying the anion exchanger and calcium salt composition to operate efficiently in specific environments. For example, in high-altitude environments, the anion exchanger is adapted to function at low oxygen levels. In high-temperature environments, the composition is formulated to maintain its hemostatic properties above 40°C. In underwater environments, the anion exchanger is adapted to function in the presence of high water pressure. In remote or isolated locations, a portable, self-contained device is used to apply the composition. In high-security environments, the composition is formulated to be detectable by security screening devices and to maintain its hemostatic properties in the presence of security screening radiation.
Novelty and Inventive Step
The new claims provide a novel and non-obvious solution by adapting the hemostatic composition to specific niche environments, which was not anticipated by the original patent. The inventive step lies in the recognition of the need for specialized hemostatic compositions and the development of tailored solutions for each environment.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include using different types of anion exchangers, varying the concentration of the calcium salt, or incorporating additional components to enhance the composition's performance in specific environments. Variations may also include using different formulations, such as gels or powders, to suit the needs of different environments.
Potential Commercial Applications and Market
The present inventive concept has significant commercial potential in various industries, including military, emergency response, and medical devices. The market for specialized hemostatic compositions is expected to grow as the need for effective bleeding control solutions in niche environments increases.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Hemostatic medical compositions, specifically chemical formulations for controlling bleeding using anion exchangers and calcium salts, requiring expertise in medical chemistry, polymer science, and emergency medical treatments
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in chemistry or biomedical engineering, understanding material science principles, familiar with hemostatic agent design, capable of adapting chemical compositions for specific environmental conditions
Obviousness Rationale
A person skilled in the art would recognize that modifying hemostatic compositions for specific environmental conditions represents a predictable engineering variation. The source patent establishes a foundational hemostatic composition that can be systematically adapted through routine experimentation. The PTD's variations represent logical extensions of known hemostatic technology by applying standard materials engineering principles to address specific operational challenges.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,564 |
|---|---|
| Title | Hemostatic composition comprising an anion exchanger and a calcium salt |
| Assignee(s) | Omrix Biopharmaceuticals Ltd. |